● Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Condition: Type 1 Diabetes Mellitus · T1D · T1DM · Sponsor: COUR Pharmaceutical Development Company, Inc.

PhasePhase 1/Phase 2

Planned participants72

Who can joinAll sexes, 12 Years to 35 Years

Healthy volunteersNo

About this study

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evaluations (275 days).

This description comes directly from the study's public registry record.

Talk to the study team

Stephanie Slaughter · 317-727-2551 · sslaughter@courpharma.com

Cristina Varela · 901-517-2602 · cvarela@courpharma.copm

Always discuss trial participation with your own doctor first.

Locations (32)

Wake Research - Tucson	Tucson, Arizona, United States	Recruiting
Liver Institute PLLC	Tucson, Arizona, United States	Recruiting
Rady Children's Hospital San Diego	San Diego, California, United States	Recruiting
Diablo Clinical Research	Walnut Creek, California, United States	Recruiting
Barbara Davis Center for Childhood Diabetes	Aurora, Colorado, United States	Recruiting
University of Florida	Gainesville, Florida, United States	Recruiting
Evolution Research Center	Hialeah, Florida, United States	Recruiting
University of Miami	Miami, Florida, United States	Recruiting
DY Professional Research Center	Miami, Florida, United States	Recruiting
University of South Florida	Tampa, Florida, United States	Recruiting
Atlanta Diabetes Association	Atlanta, Georgia, United States	Recruiting
Emory University	Atlanta, Georgia, United States	Recruiting

+ 20 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06783309